Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study

BACKGROUND: The ability of (18)F-PI-2620 PET to measure the spatial distribution of tau pathology in Alzheimer’s disease (AD) has been demonstrated in previous studies. The objective of this work was to evaluate tau deposition using (18)F-PI-2620 PET in beta-amyloid positive subjects with a diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullich, Santiago, Mueller, Andre, De Santi, Susan, Koglin, Norman, Krause, Stephen, Kaplow, June, Kanekiyo, Michio, Roé-Vellvé, Núria, Perrotin, Audrey, Jovalekic, Aleksandar, Scott, David, Gee, Michelle, Stephens, Andrew, Irizarry, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327167/
https://www.ncbi.nlm.nih.gov/pubmed/35897078
http://dx.doi.org/10.1186/s13195-022-01048-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327167/
https://www.ncbi.nlm.nih.gov/pubmed/35897078
http://dx.doi.org/10.1186/s13195-022-01048-x

Ejemplares similares